Stay updated on Obeticholic Acid in NASH Clinical Trial
Sign up to get notified when there's something new on the Obeticholic Acid in NASH Clinical Trial page.

Latest updates to the Obeticholic Acid in NASH Clinical Trial page
- Check5 days agoChange DetectedThe REGENERATE Phase 3 study record is available, documenting its termination and rationale alongside study design, eligibility, outcomes, locations, results, publications, and study documents.SummaryDifference100%

- Check12 days agoChange DetectedThe footer revision changed from v3.7.2 to v3.8.0, while the study record page continues to display a 403 error.SummaryDifference0.2%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedA site-wide NIH notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the error page. The site revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check40 days agoChange DetectedThe site revision label changed from v3.7.0 to v3.7.1 while the study page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check54 days agoChange DetectedThe Study Record page now displays a 403 Forbidden error with the site header and footer, indicating access to the page is blocked rather than showing the study details.SummaryDifference16%

- Check61 days agoChange DetectedThe revision label has been updated to v3.7.0, indicating a new software update. The previous revision v3.6.6 is no longer visible in the updated history.SummaryDifference0.0%

Stay in the know with updates to Obeticholic Acid in NASH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Obeticholic Acid in NASH Clinical Trial page.